ArticlePharmacology research & perspectives2015

Evacetrapib: in vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors.

Ellen A Cannady et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.